Watch CBS News

UCLA-led study shows new pancreatic cancer drug offers promising results

Name: UCLA-led study shows new pancreatic cancer drug offers promising results
Uploaded: 2026-06-04T17:14:00-0700
Duration: 2 min 56 s
Description: In the study, patients taking the drug lived longer than those undergoing chemotherapy, doubling the expected lifespan from 6.5 months to about 13 months on average.

In the study, patients taking the drug lived longer than those undergoing chemotherapy, doubling the expected lifespan from 6.5 months to about 13 months on average.